Tamsulosin for voiding dysfunction in women

International Urology and Nephrology

Volumn 44, Issue 6, 2012, Pages 1649-1656

  Meyer, Laura E ^a   Brown, Jamie N ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Alpha adrenergic antagonist; Lower urinary tract symptoms; Tamsulosin; Voiding dysfunction

Indexed keywords

PLACEBO; PRAZOSIN; TAMSULOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; SULFONAMIDE;

ASTHENIA; BLURRED VISION; BRISTOL FEMALE LOWER URINARY TRACT SYMPTOM QUESTIONNAIRE; CLINICAL TRIAL (TOPIC); DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPOTENSION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOCTURIA; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SLEEP QUALITY; STRESS INCONTINENCE; URINARY DYSFUNCTION; URINARY URGENCY; URINE FLOW RATE; UROGENITAL DISTRESS INVENTORY; MICTURITION DISORDER;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; FEMALE; HUMANS; LOWER URINARY TRACT SYMPTOMS; SULFONAMIDES; URINATION DISORDERS;

EID: 84877611116     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0275-0     Document Type: Review

References (28)

1. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306-1315
2. Irwin D, Kopp Z, Agatep B, Milsom I, Abrams P (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence, and bladder outlet obstruction. BJU Int 108:1132-1139
3. Milsom I (2009) Lower urinary tract symptoms in women. Curr Opin Urol 19:337-341
4. Abrams P, Cardozo L, Magnus F, Griffiths D, Rosier P, Ulmsten U, et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the international continence society. Urology 61:37-49
5. 1-adrenoreceptor antagonists. BJU Int 85(suppl 2):1-5
6. Segaran SpeakmanMJ (2011) Management of lower urinary tract symptoms and bladder outlet obstruction. Medicine 39(7):378-383
7. Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J (2009) Evaluation and treatment of lower urinary tract symptoms in older men. J Urol 181:1779-1787
8. National Institute for Health and Clinical Excellence (2010) CG97 full guideline. Lower urinary tract symptoms: the management of lower urinary tract symptoms in men. http://www.nice.org.uk/nicemedia/live/12984/48554/48554.pdf. Accessed 26 Feb 2012
9. 1d subtype in filling symptoms and effects of aging on vascular expression. BJU Int 85(suppl 2):6-11
10. 1-adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clin Ther 26:1701-1713
11. Low BY, Liong M, Yuen K, Chee C, Leong W, Chong W, et al. (2008) Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial. J Urol 179:1461-1469
12. Kessler TM, Studer U, Burkhard FC (2006) The effect of terazosin in functional bladder outlet obstruction in women: a pilot study. J Urol 176:1487-1492
13. Lepor H, Theune C (1995) Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms. J Urol 154:116-118
14. Lee Y, Lee K, Lee HS, Kim JC, Seo JT, Choo M (2011) Efficacy of alpha-blocker for the treatment of voiding dysfunction in women: 8 week, randomized, double blind, placebo-controlled, parallel group study (phase II). Neurourol Urodyn 30(6):1083-1084
15. Pummangura N, Kochakarn W (2007) Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women. Asian J Surg 30(2):131
16. Lee K, Hyun Han D, Lee Y, Choo M, Yoo T, Park H, et al. (2010) Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study. J Korean Med Sci 25(1):117-122
17. Lee S, Lee W, Lee S, Kim H, Park C (2011) The effect of tamsulosin in female patients with lower urinary tract symptoms and predictive factors for therapeutic outcome: multicenter, prospective study [abstract]. Int Urogynecol J 22(suppl 3):S1781
18. Pischedda A, Pirozzi Farina F, Madonia M, Cimino S, Morgia G (2005) Use of alpha1-blockers in female functional bladder neck obstruction. Urol Int 74:256-261
19. Ryu S, Kim S, Hwang E, Im C, Oh K, Jung S, et al. (2010) The role of alpha 1(A) adrenoreceptor antagonist tamsulosin for the treatment of patients with lower urinary tract symptoms in women: the effect of nocturia and sleep quality [abstract]. Urology 76(suppl 3A):S61
20. Hajebrahimi S, Ahmadi Asrbadr Y, Azaripour A, Sadeghi-Bazargani H (2011) Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: a randomized clinical trial. Int J Gen Med 4:35-39
21. Constantini E, Lazzeri M, Bini V, Zucchi A, Fioretti F, Frumenzio E, et al. (2009) Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol Int 83:311-315
22. National Institute for Health and Clinical Evidence (2006) CG40 UI: urinary incontinence: the management of urinary incontinence in women. http://www.nice.org.uk/nicemedia/live/10996/30282/30282.pdf. Accessed 26 Feb 2012
23. Stanton SL, Ozsoy C, Hilton P (1983) Voiding difficulties in the female: prevalence, clinical and urodynamic review. Obstet Gynecol 61:144-147
24. Patel R, Nitti VW (2001) Bladder outlet obstruction in women: prevalence, recognition, and management. Curr Urol Rep 2:379-387
25. Flomax [package insert] (2009) Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT
26. Chang SJ, Chang IN, Yu HJ (2008) The effectiveness of tamsulosin in treating women with voiding difficulty. Int J Urol 15:981-985
27. Kaneko T, Matsushima H, Morimoto H, Tsuzaka Y, Homma Y (2010) Efficacy of low dose tamsulosin in medical expulsive therapy for ureteral stones in Japanese male patients: a randomized controlled study. Int J Urol 17:462-465
28. Schagen van Leeuwen JH, Castro R, Busse M, Bemelmans B (2006) The placebo effect in the pharmacologic treatments of patients with lower urinary tract symptoms. Eur Urol 50:440-453